000 01025 a2200289 4500
005 20250517193859.0
264 0 _c20190204
008 201902s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/apt.14456
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRibaldone, D G
245 0 0 _aLetter: therapeutic drug monitoring and inflammatory bowel disease-a call for an urgent standardization of the results.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_c02 2018
300 _a448-449 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aDrug Monitoring
650 0 4 _aGastrointestinal Agents
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
650 0 4 _aInfliximab
700 1 _aSaracco, G M
700 1 _aAstegiano, M
700 1 _aPellicano, R
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 47
_gno. 3
_gp. 448-449
856 4 0 _uhttps://doi.org/10.1111/apt.14456
_zAvailable from publisher's website
999 _c27960779
_d27960779